Standard BioTools Inc. (NASDAQ:LAB) Q3 2024 Earnings Conference Call October 30, 2024 4:30 PM ET
Company Participants
David Holmes – IR
Michael Egholm – President & CEO
Alex Kim – Chief Operating Officer & Interim-CFO
Conference Call Participants
Matt Stanton – Jefferies
Operator
Good day and welcome to the Standard BioTools Inc Third Quarter 2024 Financial Results Conference Call. All participants will be in listen-only mode. After today’s presentation, There will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded.
I would now like to turn the conference over David Holmes of Investor Relations. Please go ahead.
David Holmes
Thank you, operator, and good afternoon, everyone. Welcome to Standard BioTools’ third quarter 2024 earnings conference call. Leading the call today is Michael Egholm, President and Chief Executive Officer and Alex Kim, Chief Operating Officer and interim-Chief Financial Officer.
At the close of market today, Standard BioTools released its financial results for the quarter ended September 30, 2024. During the call, we will review our results and provide an update on our financial and operational performance, 2024 outlook, market trends and strategic initiatives.
During the call, we will be making forward-looking statements about events and circumstances that have not yet occurred, including plans and projections of our business, our outlook for 2024 and future financial results, market trends and opportunities and our expectations related to the combined operations with SomaLogic, including potential synergies and our business outlook for the combined company.
These statements are subject to substantial risks and uncertainties that may cause actual events or results to differ materially from current circumstances. The forward-looking statements on this call are based on information currently available to us and we disclaim any obligation to update these statements, except as may be required by law.
During the
Read the full article here
